A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS

被引:31
|
作者
Maccari, Maria Elena [1 ,2 ]
Fuchs, Sebastian [3 ]
Kury, Patrick [1 ,4 ]
Andrieux, Geoffroy [5 ,6 ,7 ]
Volkl, Simon [8 ]
Bengsch, Bertram [9 ,10 ,11 ]
Lorenz, Myriam Ricarda [12 ,13 ]
Heeg, Maximilian [1 ,2 ]
Rohr, Jan [1 ,2 ]
Jagle, Sabine [1 ]
Castro, Carla N. [1 ]
Gross, Miriam [1 ]
Warthorst, Ursula [1 ]
Koenig, Christoph [1 ,4 ]
Fuchs, Ilka [1 ]
Speckmann, Carsten [1 ,2 ]
Thalhammer, Julian [1 ,2 ]
Kapp, Friedrich G. [2 ]
Seidel, Markus G. [14 ]
Duckers, Gregor [15 ]
Schoenberger, Stefan [16 ]
Schuetz, Catharina [17 ]
Fuhrer, Marita [12 ,13 ]
Kobbe, Robin [18 ]
Holzinger, Dirk [19 ]
Klemann, Christian [20 ]
Smisek, Petr [21 ,22 ]
Owens, Stephen [23 ,24 ]
Horneff, Gerd [25 ,26 ]
Kolb, Reinhard [27 ]
Naumann-Bartsch, Nora [28 ]
Miano, Maurizio [29 ]
Staniek, Julian [4 ,30 ]
Rizzi, Marta [1 ,30 ]
Kalina, Tomas [31 ,32 ]
Schneider, Pascal [33 ]
Erxleben, Anika [34 ]
Backofen, Rolf [34 ]
Ekici, Arif [35 ]
Niemeyer, Charlotte M. [2 ]
Warnatz, Klaus [1 ]
Grimbacher, Bodo [36 ,37 ]
Eibel, Hermann [1 ]
Mackensen, Andreas [8 ]
Frei, Andreas Philipp [3 ]
Schwarz, Klaus [12 ,13 ]
Boerries, Melanie [5 ,6 ,7 ]
Ehl, Stephan [1 ,2 ,10 ]
Rensing-Ehl, Anne [1 ]
机构
[1] Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency, Inst Immunodeficiency,Med Ctr, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Med Ctr, Div Pediat Hematol & Oncol,Dept Pediat & Adolesce, Freiburg, Germany
[3] Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev Immunol Infect Dis &, Basel, Switzerland
[4] Univ Freiburg, Fac Biol, Freiburg, Germany
[5] Univ Freiburg, Fac Med, Med Ctr, Inst Med Bioinformat & Syst Med, Freiburg, Germany
[6] German Canc Consortium, Freiburg, Germany
[7] German Canc Res Ctr, Heidelberg, Germany
[8] Univ Erlangen Nurnberg, Dept Internal Med Hematol Oncol 5, Erlangen, Germany
[9] Univ Freiburg, Fac Med, Dept Med Gastroenterol Hepatol Endocrinol & Infec, Med Ctr, Freiburg, Germany
[10] Albert Ludwigs Univ, Ctr Integrat Biological Signaling Studies, Freiburg, Germany
[11] Univ Freiburg, Bioss Ctr Biol Signalling Studies, Freiburg, Germany
[12] Univ Ulm, Inst Transfus Med, Ulm, Germany
[13] German Red Cross Blood Serv Baden Wuerttemberg He, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany
[14] Med Univ Graz, Dept Pediat & Adolescent Med, Div Pediat Hematol Oncol, Graz, Austria
[15] Childrens Hosp, Helios Kliniken Krefeld, Krefeld, Germany
[16] Univ Bonn, Univ Childrens Hosp Bonn, Dept Paediat Haematol & Oncol, Bonn, Germany
[17] Tech Univ Dresden, Dept Pediat, Univ Hosp Carl Gustav Carus, Dresden, Germany
[18] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Div Infect Dis, Hamburg, Germany
[19] Univ Duisburg Essen, Dept Pediat Hematol Oncol, Essen, Germany
[20] Hannover Med Sch, Dept Pediat Pulmonol Allergy & Neonatol, Hannover, Germany
[21] Univ Hosp Motol, Dept Pediat Hematol & Oncol, Prague, Czech Republic
[22] Charles Univ Prague, Fac Med 2, Prague, Czech Republic
[23] Newcastle Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[24] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England
[25] Clin Sankt Augustin, Dept Gen Paediat, St Augustin, Germany
[26] Univ Hosp Cologne, Dept Pediat & Adolescent Med, Cologne, Germany
[27] Clin Oldenburg, Dept Gen Paediat, Oldenburg, Germany
[28] Friedrich Alexander Univ Erlangen Nurnberg, Dept Pediat, Erlangen, Germany
[29] Ist Ricovero & Cura Carattere Sci Ist Giannina Ga, Haematol Unit, Genoa, Italy
[30] Univ Freiburg, Fac Med, Dept Rheumatol & Clin Immunol, Med Ctr, Freiburg, Germany
[31] Charles Univ Prague, Sch Med 2, Dept Pediat Hematol & Oncol, Childhood Leukemia Invest Prague, Prague, Czech Republic
[32] Univ Hosp Motol, Prague, Czech Republic
[33] Univ Lausanne, Dept Biochem, Epalinges, Switzerland
[34] Univ Freiburg, Inst Comp Sci, Fac Engn, Bioinformat, Freiburg, Germany
[35] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany
[36] Satellite Ctr, German Ctr Infect Res, Freiburg, Germany
[37] Hanover Med Sch, Satellite Ctr, Resolving Infect Susceptibil Cluster Excellence 2, Freiburg, Germany
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2021年 / 218卷 / 02期
关键词
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; SYNDROME EXPRESS; APOPTOSIS; DEATH; MUTATIONS; EFFECTOR; DIFFERENTIATION; VISUALIZATION; INACTIVATION; ACTIVATION;
D O I
10.1084/jem.20192191
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The identification and characterization of rare immune cell populations in humans can be facilitated by their growth advantage in the context of specific genetic diseases. Here, we use autoimmune lymphoproliferative syndrome to identify a population of FAS-controlled TCR alpha beta(+) T cells. They include CD4(+), CD8(+), and double-negative T cells and can be defined by a CD38(+)CD45RA(+)T-BET- expression pattern. These unconventional T cells are present in healthy individuals, are generated before birth, are enriched in lymphoid tissue, and do not expand during acute viral infection. They are characterized by a unique molecular signature that is unambiguously different from other known T cell differentiation subsets and independent of CD4 or CD8 expression. Functionally, FAS-controlled T cells represent highly proliferative, noncytotoxic T cells with an IL-10 cytokine bias. Mechanistically, regulation of this physiological population is mediated by FAS and CTLA4 signaling, and its survival is enhanced by mTOR and STAT3 signals. Genetic alterations in these pathways result in expansion of FAS-controlled T cells, which can cause significant lymphoproliferative disease.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] Canine CD4+ CD8+ double-positive T cells can develop from CD4+ and CD8+ T cells
    Bismarck, Doris
    Moore, Peter F.
    Alber, Gottfried
    von Buttlar, Heiner
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2014, 162 (3-4) : 72 - 82
  • [2] Invariant or highly conserved TCR α are expressed on double-negative (CD3+CD4-CD8-) and CD8+ T cells
    Han, M
    Harrison, L
    Kehn, P
    Stevenson, K
    Currier, J
    Robinson, MA
    [J]. JOURNAL OF IMMUNOLOGY, 1999, 163 (01): : 301 - 311
  • [3] Heterogeneity of CD4+ and CD8+ T cells
    Woodland, DL
    Dutton, RW
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (03) : 336 - 342
  • [4] Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency
    Rensing-Ehl, Anne
    Voelkl, Simon
    Speckmann, Carsten
    Lorenz, Myriam Ricarda
    Ritter, Julia
    Janda, Ales
    Abinun, Mario
    Pircher, Hanspeter
    Bengsch, Bertram
    Thimme, Robert
    Fuchs, Ilka
    Ammann, Sandra
    Allgaeuer, Andrea
    Kentouche, Karim
    Cant, Andrew
    Hambleton, Sophie
    da Cunha, Claudia Bettoni
    Huetker, Sebastian
    Kuehnle, Ingrid
    Pekrun, Arnulf
    Seidel, Markus G.
    Hummel, Michael
    Mackensen, Andreas
    Schwarz, Klaus
    Ehl, Stephan
    [J]. BLOOD, 2014, 124 (06) : 851 - 860
  • [5] Differentiation of subsets of CD4+ and CD8+ T cells
    Mosmann, TR
    Sad, S
    Krishnan, L
    Wegmann, TG
    Guilbert, LJ
    Belosevic, M
    [J]. T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES, 1995, 195 : 42 - 50
  • [6] The dual functions of Fas ligand in the regulation of peripheral CD8+ and CD4+ T cells
    Suzuki, I
    Fink, PJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) : 1707 - 1712
  • [7] Expression of naive/memory (CD45RA/CD45RO) markers by peripheral blood CD4+ and CD8+ T cells in children with asthma
    Edyta Machura
    Bogdan Mazur
    Wojciech Pieniążek
    Krystyna Karczewska
    [J]. Archivum Immunologiae et Therapiae Experimentalis, 2008, 56 : 55 - 62
  • [8] Expression of naive/memory (CD45RA/CD45RO) markers by peripheral blood CD4+ and CD8+ T cells in children with asthma
    Machura, Edyta
    Mazur, Bogdan
    Pieniazek, Wojciech
    Karczewska, Krystyna
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2008, 56 (01) : 55 - 62
  • [9] CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer
    Wu, Zhiheng
    Zheng, Yu
    Sheng, Jin
    Han, Yicheng
    Yang, Yanyan
    Pan, Hongming
    Yao, Junlin
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] JNK and p38 MAP kinases in CD4+ and CD8+ T cells
    Rincón, M
    Pedraza-Alva, G
    [J]. IMMUNOLOGICAL REVIEWS, 2003, 192 (01) : 131 - 142